284
Views
13
CrossRef citations to date
0
Altmetric
Case Report

Fondaparinux cross-reactivity in heparin-induced thrombocytopenia successfully treated with high-dose intravenous immunoglobulin and rivaroxaban

ORCID Icon, ORCID Icon, & ORCID Icon
Pages 124-127 | Received 13 Jun 2019, Accepted 22 Jul 2019, Published online: 09 Aug 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Anne-Mette Hvas, Emmanuel J Favaloro & Maja Hellfritzsch. (2021) Heparin-induced thrombocytopenia: pathophysiology, diagnosis and treatment. Expert Review of Hematology 14:4, pages 335-346.
Read now

Articles from other publishers (12)

Theodore E. Warkentin. (2023) Autoimmune Heparin-Induced Thrombocytopenia. Journal of Clinical Medicine 12:21, pages 6921.
Crossref
Payel Datta, Fuming Zhang, Jonathan S. Dordick & Robert J. Linhardt. (2021) Platelet factor 4 polyanion immune complexes: heparin induced thrombocytopenia and vaccine-induced immune thrombotic thrombocytopenia. Thrombosis Journal 19:1.
Crossref
Nicholas Munafo, Sagar Patel, Kristine C. Willett & Amanda Morrill. (2021) Oral Factor Xa (FXa) Inhibitors for Treatment of Heparin-induced Thrombocytopenia (HIT). Current Drug Therapy 16:2, pages 126-132.
Crossref
John A. Dougherty & Robyn Lupoli Yarsley. (2020) Intravenous Immune Globulin (IVIG) for Treatment of Autoimmune Heparin-Induced Thrombocytopenia: A Systematic Review. Annals of Pharmacotherapy 55:2, pages 198-215.
Crossref
Seohyun (Claudia) Choi, Danielle Tompkins, Jessica Wilczynski & Caitlin E. Kulig. 2021. 393 414 .
Chinonso Onuoha, Karen D. Barton, Edward C.C. Wong, Jay S. Raval, Marian A. Rollins‐Raval, Tina S. Ipe, Joseph E. Kiss, Leonard I. Boral, Jill Adamksi, Nicole D. Zantek & Oluwatoyosi A. Onwuemene. (2020) Therapeutic plasma exchange and intravenous immune globulin in the treatment of heparin‐induced thrombocytopenia: A systematic review . Transfusion 60:11, pages 2714-2736.
Crossref
Zheng Cai, Mark I. Greene, Zhiqiang Zhu & Hongtao Zhang. (2020) Structural Features and PF4 Functions that Occur in Heparin-Induced Thrombocytopenia (HIT) Complicated by COVID-19. Antibodies 9:4, pages 52.
Crossref
Nicholas G. Kounis, Ioanna Koniari, George D. Soufras, Grigorios Tsigkas, Panagiotis Plotas, Periklis Davlouros & George Hahalis. (2020) The paradox of heparin induced thrombocytopenia-thrombosis, the role of fondaparinux and the need for new therapeutic strategies. International Angiology 39:4.
Crossref
Michelangelo Sartori & Benilde Cosmi. (2020) Failure of Fondaparinux in Autoimmune Heparin-Induced Thrombocytopenia. TH Open 04:04, pages e305-e308.
Crossref
Mohamed Aon & Omar Al-Shammari. (2020) Rivaroxaban Treatment for Heparin-Induced Thrombocytopenia: A Case Report and a Review of the Current Experience. Case Reports in Hematology 2020, pages 1-5.
Crossref
Seohyun (Claudia) Choi, Jessica Wilczynski, Danielle Tompkins & Jimmy Gonzalez. 2020. A Worldwide Yearly Survey of New Data in Adverse Drug Reactions. A Worldwide Yearly Survey of New Data in Adverse Drug Reactions 337 360 .
. (2020) Fondaparinux sodium/heparin. Reactions Weekly 1785:1, pages 244-244.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.